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Background: Plant-based foods have been used in traditional health systems to treat diabetes mellitus. The
successful prevention of the onset of diabetes consists in controlling postprandial hyperglycemia by the inhibition
of α-glucosidase and pancreatic α-amylase activities, resulting in aggressive delay of carbohydrate digestion to
absorbable monosaccharide. In this study, five plant-based foods were investigated for intestinal α-glucosidase and
pancreatic α-amylase. The combined inhibitory effects of plant-based foods were also evaluated. Preliminary
phytochemical analysis of plant-based foods was performed in order to determine the total phenolic and flavonoid
content.
Methods: The dried plants of Hibiscus sabdariffa (Roselle), Chrysanthemum indicum (chrysanthemum), Morus alba
(mulberry), Aegle marmelos (bael), and Clitoria ternatea (butterfly pea) were extracted with distilled water and dried
using spray drying process. The dried extracts were determined for the total phenolic and flavonoid content by
using Folin-Ciocateu’s reagent and AlCl3 assay, respectively. The dried extract of plant-based food was further
quantified with respect to intestinal α-glucosidase (maltase and sucrase) inhibition and pancreatic α-amylase
inhibition by glucose oxidase method and dinitrosalicylic (DNS) reagent, respectively.
Results: The phytochemical analysis revealed that the total phenolic content of the dried extracts were in the
range of 230.3-460.0 mg gallic acid equivalent/g dried extract. The dried extracts contained flavonoid in the range
of 50.3-114.8 mg quercetin equivalent/g dried extract. It was noted that the IC50 values of chrysanthemum,
mulberry and butterfly pea extracts were 4.24±0.12 mg/ml, 0.59±0.06 mg/ml, and 3.15±0.19 mg/ml, respectively. In
addition, the IC50 values of chrysanthemum, mulberry and butterfly pea extracts against intestinal sucrase were
3.85±0.41 mg/ml, 0.94±0.11 mg/ml, and 4.41±0.15 mg/ml, respectively. Furthermore, the IC50 values of roselle and
butterfly pea extracts against pancreatic α-amylase occurred at concentration of 3.52±0.15 mg/ml and
4.05±0.32 mg/ml, respectively. Combining roselle, chrysanthemum, and butterfly pea extracts with mulberry extract
showed additive interaction on intestinal maltase inhibition. The results also demonstrated that the combination of
chrysanthemum, mulberry, or bael extracts together with roselle extract produced synergistic inhibition, whereas
roselle extract showed additive inhibition when combined with butterfly pea extract against pancreatic α-amylase.
Conclusions: The present study presents data from five plant-based foods evaluating the intestinal α-glucosidase
and pancreatic α-amylase inhibitory activities and their additive and synergistic interactions. These results could be
useful for developing functional foods by combination of plant-based foods for treatment and prevention of
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Table 1 The list of plant-based foods was used of this
study
Plant samples
Common name Scientific name Family Used part
Roselle Hibiscus sabdariffa Malvaceae Flower
Chrysanthemum Chrysanthemum indicum Compositae Flower
Mulberry Morus alba Moraceae Leaves
Bael Aegle marmelos Rutaceae Fruit
Butterfly pea Clitoria ternatea Leguminosae Flower
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Diabetes mellitus is an endocrine and metabolic disorder
characterized by chronic hyperglycemia, dyslipidemia,
and protein metabolism that result from defects in both
regulations of insulin secretion and/or insulin action.
There has been a dramatic increase in the number of
diabetic patients worldwide because of changes in life-
style and diet. Consumption of high-carbohydrate diets
causes elevated postprandial hyperglycemia that can pro-
gress to full symptomatic type 2 diabetes [1]. Current
therapeutic strategy for the control of postprandial
hyperglycemia is the inhibition of α-glucosidase and α-
amylase, resulting in aggressive delay of carbohydrate di-
gestion to absorbable monosaccharide [2]. α-Glucosidase
inhibitor has been recognized as a therapeutic approach
for modulation of postprandial hyperglycemia, which is
the earliest metabolic defect to occur in type 2 diabetes.
Current evidence supports the claim that the known α-
glucosidase inhibitors such as acarbose and voglibose
potentially reduce the progression of diabetes as well as
micro- and macrovascular complications including dia-
betic retinopathy, nephropathy, and neuropathy [3].
However, it has been reported that α-glucosidase and
pancreatic α-amylase inhibitors are associated with
gastrointestinal side effects such as abdominal pain,
flatulence, meteorism, and diarrhea in the diabetic
patients [4]. Thus, efforts have been directed at investi-
gating intestinal α-glucosidase and pancreatic α-amylase
inhibitors from plant-based foods that are largely free of
major undesirable side effects.
Many plant-based foods are good sources of unique
phytochemical compounds such as polyphenols and fla-
vonoids. Recent studies have shown that plant-based
foods containing high total polyphenolic compounds
and flavonoids yield can be linked to intestinal α-
glucosidase and pancreatic α-amylase inhibitory activ-
ities in vitro [5-8]. However, the therapeutic approaches
from administration of single plant-based food may be
not adequate to assess the delay of carbohydrate diges-
tion. Many scientists have investigated the combination
of different plant-based foods containing various phyto-
chemicals that exhibit additive and synergistic inter-
action in antidiabetic and antioxidant properties that
exert positive health-promoting effects, leading to the
development of functional foods [9,10]. Hence, we are
particularly interested in investigating the inhibitory ef-
fect of these plant-based foods and their interactions on
the intestinal α-glucosidase and pancreatic α-amylase.
For this purpose, a total of 5 plant-based foods were
selected, including butterfly pea, mulberry, roselle, bael,
and chrysanthemum, which are consumed daily as part
of a main meal and beverages in Southeast Asia. Actu-
ally, these edible plants are commonly consumed in the
form of water extract. Moreover, it is clear that solublephenolic and flavonoid compounds can be extracted
using water. Therefore, total phenolic and flavonoid con-
tent in all plant-based foods were also evaluated.Methods
Chemical
Folin-Ciocateu’s reagent, quercetin, gallic acid, rat intes-
tinal acetone powder, porcine pancreatic α-amylase, glu-
cose oxidase kits and 3,5-dinitrosalicylic acid were
purchased from Sigma-Aldrich Co. (St. Louis, MO,
USA). All other chemical reagents used in this study
were of analytical grade.Collection and extraction
The plants materials were collected from the local mar-
ket in Bangkok, Thailand (Table 1) The extraction of the
plants was performed according to a previous method
[11]. The dried plant materials were subjected to size re-
duction to a coarse powder by using a dry grinder. The
dried plants (200 g) were extracted with distilled water
(1,000 ml) at 90°C for 2 h. The samples were filtered
through Whatman 70 mm filter paper. The solution was
then centrifuged at 8,000 rpm for 10 min. The aqueous
solution was dried using a spray dryer SD-100 (Eyela
world, Tokyo Rikakikai Co., LTD, Japan). The spray dry-
ing conditions used in the study were inlet temperature
(164–168°C), outlet temperature (71–78°C), blower
(0.70-0.79 m3/min) and atomizing (80–90 kPa).Determination of total phenolic content
Total phenolic content of extracts was performed
according to a previous method [11]. The dried extract
(0.5 mg) was dissolved in distilled w (1 ml). The sample
solution (50 μl) was mixed with 50 μl of Folin-Ciocateu’s
reagent followed by 50 μl of Na2CO3 (10%w/v). After in-
cubation at 30°C for 60 min, the absorbance was then
measured at 760 nm using a microplate reader (BioTek
Instruments, Inc., USA). Total phenolic content was cal-
culated from a calibration curve using gallic acid as a
standard. The results were expressed as milligram gallic
acid equivalent/gram dry weight of extract.
Table 2 Total phenolic compounds and flavonoids in
plant-based foods
Phytochemical analysis
Samples Phenolic content Flavonoid content
(mg/g dried extract) (mg/g dried extract)
Roselle 460.00±1.34 50.29±2.38
Chrysanthemum 226.67± 6.67 114.77±1.10
Mulberry 260.00±20.00 58.09±2.32
Bael 433.33±17.64 44.57±2.65
Butterfly pea 233.33±17.64 78.28±1.47
Results are expressed as means ± S.E.M., n = 3.
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Estimation of flavonoid content in the dried extracts was
done according to a previous method [11]. The dried ex-
tract (0.5 mg) was dissolved in 80% ethanol (1 ml). The
sample solution (50 μl) was added to 10 μl of AlCl3 solu-
tion (10%w/v) and 10 μl of 1 M sodium acetate in abso-
lute ethanol (150 μl). After incubation at 30°C for
30 min, the absorbance was measured immediately at
430 nm. The estimation of flavonoid content was calcu-
lated from a calibration curve using quercetin as a
standard. The results were expressed as milligram quer-
cetin equivalent/gram dry weight of extract.
Intestinal α-glucosidase inhibitory activity
The assessment of intestinal α-glucosidase inhibitory ac-
tivity was based on the modified method previously
described [12]. Briefly, 100 mg of rat intestinal acetone
powder was homogenized in 3 ml of 0.9% NaCl solution.
The solution was centrifuged at 12,000 g for 30 min and
then subjected to assay. The crude enzyme solution (as
maltase assay, 10 μl; as sucrase assay, 30 μl) was incu-
bated with 30 μl maltose (86 mM) or 40 μl sucrose
(400 mM), 10 μl of the extract at various concentrations,
followed by the addition of 0.1 M phosphate buffer, pH
6.9 to give a final volume of 100 μl. The reaction was
incubated at 37°C for 30 min (maltase assay) or 60 min
(sucrase assay). Thereafter, the mixtures were suspended
in boiling water for 10 min to stop the reaction. The
concentrations of glucose released from the reaction
mixtures were determined by glucose oxidase method
with absorbance at a wavelength of 450 nm. Intestinal α-
glucosidase inhibitory activity was expressed as percent-
age inhibition using the following formula.
% Inhibition
¼ AbsControl  AbsSample
AbsControl
100
Where AbsControl was the absorbance without sample,
Abssamples was the absorbance of sample extract.
Pancreatic α-amylase inhibitory activity
The pancreatic α-amylase inhibition assay was per-
formed according to a previous report [12]. Porcine pan-
creatic α-amylase (3 units/ml) was dissolved in 0.1 M
phosphate buffer saline, pH 6.9. The various concentra-
tions of the extract (10 μl) were added to a solution con-
taining starch (1 g/l) and phosphate buffer (165 μl). The
reaction was initiated by adding enzyme solution (75 μl)
to the incubation medium. After 10 min incubation, the
reaction was stopped by adding 250 ml dinitrosalicylic
(DNS) reagent (1% 3,5-dinitrosalicylic acid, 0.2% phenol,
0.05% Na2SO3 and 1% NaOH in aqueous solution) to
the reaction mixture. The mixtures were heated at 100°Cfor 10 min in order to stop the reaction. Thereafter,
250 μl of 40% potassium sodium tartarate solution was
added to the mixtures to stabilize the color. After
cooling to room temperature in a cold water bath, the
absorbance was recorded at 540 nm using a microplate
reader.
% Inhibition
¼ AbsControl  AbsSample
AbsControl
100
Where AbsControl was the absorbance without sample,
Abssamples was the absorbance of sample extract.
The intestinal α-glucosidase and pancreatic α-amylase
inhibitory activities in plant-based food combinations
The combined effect of extract was determined by mix-
ing in pairs at final concentration of 0.2 mg/ml for intes-
tinal α-glucosidase inhibition and 2.0 mg/ml for
pancreatic α-amylase inhibition. The reaction was per-
formed according to the above assay. Results were
expressed as the percentage inhibition of the corre-
sponding control values.
Data analysis
The IC50 values were calculated from plots of log con-
centration of inhibitor concentration versus percentage
inhibition curves. The data were expressed as mean ±
standard error (SE) for n= 3. Statistical analysis was per-
formed by Student’s t-test. P< 0.001 was considered to
be statistically significant.
Results
Total phenolic and flavonoid content
The list of plant-based foods used in this study is pre-
sented in Table 1. The results of total phenolic and fla-
vonoid content of 5 plant-based foods are shown in
Table 2. The total phenolic content of the extracts were
in the range of 226.67-460.00 mg gallic acid equivalent/
g dried extract. Among the extracts, the highest and
lowest content of total phonolic compound were
Table 3 The IC50 values of plant-based foods against










Roselle >5 >5 3.52±0.15
Chrysanthemum 4.24±0.12 3.85±0.41 >5
Mulberry 0.59±0.06 0.94±0.11 >5
Bael >5 >5 >5
Butterfly pea 3.15±0.19 4.41±0.15 4.05±0.32
Results are expressed as means ± S.E.M., n = 3.
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spectively. The extracts contained flavonoid in the range
of 50.3-114.8 mg quercetin equivalent/g dried extract.
The highest flavonoid content was in chrysanthemum
extract, whereas the lowest flavonoid content was
observed in bael extract.
The inhibitory effect of extracts on α-glucosidase and
α-amylase activities
The results in Figure 1 demonstrate the percentage in-
hibition of 5 plant-based foods against the intestinal α-
glucosidase (maltase and sucrase). At concentration of
1 mg/ml, five plant-based foods markedly inhibited in-
testinal maltase, ranging from 10.8-60.28%. The intes-
tinal maltase inhibitory activity was in the following
order, from highest to lowest: mulberry> butterfly pea>
chrysanthemum> roselle ﬃ bael. After plotting of per-
cent inhibition vs. log concentration of the extract, it
was noted that the IC50 values of chrysanthemum, mul-
berry, and butterfly pea extracts were 4.24±0.12 mg/ml,
0.59±0.06 mg/ml, and 3.15±0.19 mg/ml, respectively
(Table 3). In the meantime, 5 plant-based foods (1 mg/
ml) inhibited the intestinal sucrase, ranging from 26.8-
51.0%. It was found that the IC50 values of chrysanthe-
mum, mulberry and butterfly pea extracts against
intestinal sucrase were 3.85±0.41 mg/ml, 0.94±0.11 mg/
ml, and 4.41±0.15 mg/ml, respectively. We found that
roselle and bael extracts showed low α-glucosidase in-
hibition (the IC50 values> 5 mg/ml).
At the concentration of 2.5 mg/ml, the pancreatic α-
amylase inhibitory activity was in the following order,
from highest to lowest: roselle> butterfly pea> chrysan-
themum> bael>mulberry. The IC50 values of roselle
and butterfly pea extracts occurred at concentrations of
3.52±0.15 mg/ml, and 4.05±0.32 mg/ml, respectively. InFigure 1 The inhibitory effect of five plant-based foods on intestinal
results are expressed as means ± S.E.M., n = 3.the meantime, chrysanthemum, mulberry and bael
extracts showed low α-glucosidase inhibition (the IC50
values> 5 mg/ml).
The combined inhibitory effect of extracts on α-glucosidase
and α-amylase activities
To investigate specific combinations of plant-based
foods that demonstrate synergistic or additive interac-
tions, we selected mulberry, which showed the most po-
tent intestinal maltase and sucrase inhibitory activities,
to perform the assay as described earlier. The inhibitory
effect of mulberry and its combination on intestinal
maltase are shown in Figure 2. At the final concentration
of 0.2 mg/ml, the percentage intestinal maltase inhib-
ition of roselle, chrysanthemum, and butterfly pea
extracts was 9.23 ± 1.73%, 26.67 ± 0.855%, and
24.52 ± 0.55%, respectively. Upon addition of mulberry
extract to the solution, the percentage intestinal maltase
inhibition of the mixtures significantly increased to
48.19 ± 0.53%, 61.08 ± 1.73% and 50.55 ± 2.83%,glucosidase (1 mg/ml) and pancreatic α-amylase (2.5 mg/ml). The
Figure 2 The percentage intestinal maltase of combinatorial plant-based foods (0.2 mg/ml) with mulberry (0.2 mg/ml). The results are
expressed as means ± S.E.M., n = 3. * P< 0.001 compared to mulberry alone.
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alone (42.84 ± 0.85%), the percentage inhibition of mix-
tures was nearly equal to the sum effect of mulberry and
individual extract, which suggests that mulberry addi-
tively interacted with roselle, chrysanthemum, and
butterfly pea on intestinal maltase inhibition. In the
meanwhile, there was no increase in the percentage of
intestinal maltase inhibition when bael extract was
mixed with mulberry extract. The inhibitory effect of
mulberry and its combination on intestinal sucrase are
shown in Figure 3. When each extract (0.2 mg/ml) was
added to mixture containing mulberry extract (0.2 mg/
ml), it was found that there were no significant differ-
ences in the percentage inhibition of the mixtures, as
compared to mulberry alone.
To determine the combined effect of plant-based foods
on the inhibition of pancreatic α-amylase, roselle was
selected due to its demonstrating the highest inhibitoryFigure 3 The percentage intestinal sucrase of combinatorial plant-ba
expressed as means ± S.E.M., n = 3. *P< 0.001 compared to mulberry aloneactivity. Figure 4 depicts the inhibitory effect of roselle
(2.0 mg/ml) and its combination with pancreatic α-
amylase activity. In comparison, the individual pancre-
atic α-amylase activities of roselle, chrysanthemum,
mulberry, bael, and butterfly pea extracts (2.0 mg/ml)
were 18.99 ± 1.39%, 20.01 ± 0.86%, 1.17 ± 0.74%,
15.26 ± 2.06%, and 29.88 ± 1.34%, respectively. Significant
increase in the percentage inhibition was observed when
roselle extract was combined with chrysanthemum
(72.60±0.89%), mulberry (65.75±0.60%), and bael extracts
(44.40±1.11%). The results indicated that the percentage
inhibition of the mixtures was greater than that sum effect
of individual roselle and those extracts, indicating that
combination of chrysanthemum, mulberry, or bael with
roselle produced synergistic inhibition against pancreatic
α-amylase. When roselle extract (18.99±1.39%) was com-
bined with butterfly pea extract (29.88±1.34%), the per-
centage inhibition (39.97±1.18%) was nearly equal to thesed foods (0.2 mg/ml) with mulberry (0.2 mg/ml). The results are
.
Figure 4 The percentage pancreatic α-amylase of combinatorial plant-based foods (2.0 mg/ml) with roselle (2.0 mg/ml). Results are
expressed as means ± S.E.M., n = 3. *P< 0.001 compared to roselle alone.
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that the combination of roselle and butterfly pea exerted
additive inhibition against pancreatic α-amylase.
Discussion
In the present study, we investigated five plant-based
foods (H. sabdariffa (roselle); C. indicum (chrysanthe-
mum); M. alba (mulberry); A. marmelos (bael); and C.
ternatea (butterfly pea)) with anti-diabetic properties for
intestinal α-glucosidase and pancreatic α-amylase inhibi-
tory activities. The study also determined their com-
bined inhibitory effects against intestinal α-glucosidase
and pancreatic α-amylase. H. sabdariffa is cultivated
mainly for its flowers, which are used in food applications
and/or traditional medicine [13]. Chemical constituents
reported in roselle flowers are phenolic compounds (pro-
tocatechuic acid), anthocyanins (cyanidin-3-glucoside),
and hibiscus acid [13]. Our investigation reported that
roselle extract was a potent pancreatic α-amylase inhibi-
tor. Earlier studies indicate that the 50% aqueous metha-
nolic extract of roselle has high inhibitory activity against
pancreatic α-amylase, which is consistent with the results
obtained in the present study [14]. Furthermore, the pre-
vious studies indicate that hibiscus acid and cyanidin-3-
glucoside from roselle are an active pancreatic α-amylase
inhibitor [15,16]. Therefore, it can be assumed that the
inhibitory effect of roselle on pancreatic α-amylase may
be related to these compounds.
The flower of C. indicum (chrysanthemum) is an herb
widely used in traditional medicine in Southeast Asia for
anti-inflammatory, analgesic, antipyretic purposes and
the treatment of eye diseases [17]. The chemical content
in C. indicum flower includes flavonoids, and flavonoid
glycosides such as rutin, quercetin-3-glucoside, myrice-
tin, quercitrin, and luteolin [17]. In the present study, C.
indicum extract showed negligible pancreatic α-amylaseinhibition, whereas it slightly inhibited intestinal maltase
and sucrase activities.
The leaves of M. alba (mulberry) have been used in
traditional medicine for treatment of diabetes mellitus. Re-
cent documentation reveals that 1-deoxynojirimycin
(DNJ) and its derivatives, the major component in mul-
berry leaves, inhibit intestinal α-glucosidases, resulting in
delayed carbohydrate digestion [18]. In addition, the previ-
ous findings support the contention that administration of
mulberry leaf extract significantly reduces postprandial
hyperglycemia in both non-obese diabetic and healthy ani-
mals [19]. Results in this study indicated that mulberry ex-
tract had the highest inhibitory activity against intestinal
α-glucosidase, whereas it had no inhibitory activity on
pancreatic α-amylase. With regard to the antidiabetic ef-
fect of acarbose, the use of this drug is reported to be
associated with gastrointestinal side effects caused by the
excessive inhibition of pancreatic α-amylase, resulting in
the abnormal bacterial fermentation of undigested carbo-
hydrates in the large intestine [20,21]. Kwon et al. sug-
gested that plant-based foods have lower inhibitory effect
against α-amylase activity and stronger inhibitory activity
against α-glucosidase, indicating that they may be effective
therapeutic agents for the control of postprandial hyper-
glycemia with fewer side effects than acarbose [22].
A. marmelos (bael) is a tropical fruit native to South-
east Asian countries such as Sri Lanka, Pakistan, Bangla-
desh, Myanmar, and Thailand [23]. The fruits of bael are
widely used in food beverage and/or traditional medi-
cine. It has been reported that oral administration of
bael fruit extract results in significant reduction in blood
glucose, plasma thiobarbituric acid reactive substances,
hydroperoxides, and ceruloplasmin in diabetic rats [24].
The bioactive compounds in bael fruit contain carote-
noids, phenolics, alkaloids, coumarins, flavonoids, terpe-
noids, and other antioxidants [25].
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ally been used as a remedy for various diseases like urino-
genital disorder, diuretic, anthelmintic, rheumatism,
demulcent and anticancer [26]. Additionally, it has been
scientifically studied for hypoglycemic property in alloxan-
induced diabetic rats [27]. The phytochemical compounds
in the flower contain delphinidin-3,5-diglucoside,
delphinidin-3-glucoside, malvidin-3-glucoside, kaemferol
and cyanidin [26]. In a present study, the extracts demon-
strated the moderate intestinal α-glucosidase and pancre-
atic α-amylase inhibitory activities.
Inhibition of intestinal α-glucosidase and pancreatic
α-amylase activities leads to retardation of starch hydroly-
sis, resulting in delayed rise in postprandial hyperglycemia
[2]. It is obvious that polyphenols and flavonoids have
been shown to inhibit intestinal α-glucosidase and pancre-
atic α-amylase in vitro [5-8]. Importantly, it has been
reported that there is a positive relationship between the
total polyphenol and flavonoid content and the ability to
inhibit intestinal α-glucosidase and pancreatic α-amylase
[28-30]. These correlations may explain why the inhibitory
effects of plant-based food on pancreatic α-amylase and
intestinal α-glucosidase may be mediated by the action of
phenolic and flavonoids compounds.
To date, there have been no scientific studies on the ef-
fect of the combination of plant-based foods on inhibition
of pancreatic α-amylase and intestinal α-glucosidase. We
hypothesized that the efficacy of pancreatic α-amylase and
intestinal α-glucosidase inhibition can be increased by the
combination of these extracts. Our findings indicate that
mulberry showed additive inhibition on intestinal maltase
when combined with roselle, chrysanthemum and butter-
fly pea. It is interesting to note that roselle produced syn-
ergistic inhibition on pancreatic α-amylase when
combined with mulberry, chrysanthemum and bael,
whereas it showed additive inhibition when combined
with butterfly pea. The study revealed that the inhibition
of enzyme directly leads to an increase of hydrophilic and
decrease of hydrophobic properties, leading to a failure of
the formation of the active center [31]. The molecular
interaction of chemical compounds in these plants on the
synergistic effect remains unclear. We hypothesized that
hibiscus acid and cyanidin-3-glucoside in roselle contains
hydroxyl groups in the chemical structure, which can
form hydrogen bonds with the polar groups in the allo-
steric site, situated at the entrance to the catalytic site,
where other chemical compounds found in mulberry,
chrysanthemum and bael bind. The results of the interac-
tions would change the enzyme’s molecular configuration
and hydrophilic and hydrophobic properties, resulting in a
decrease in enzyme activities. Further study is needed to
characterize the synergistic effect of chemical compounds
in these extracts regarding hydrophilic and hydrophobic
properties of pancreatic α-amylase.As a consequence of the results, it is possible to in-
crease the efficacy of intestinal maltase and pancreatic
α-amylase inhibition by combination with these extracts.
Based on the results, mulberry has α-glucosidase inhibi-
tory activity, whereas roselle exhibits pancreatic α-
amylase activity, which can be combined with other
plant-based foods and produce the additive and synergis-
tic interactions. The additive and synergistic effects may
have positive health implications for individuals attempt-
ing to increase the inhibitory intestinal maltase and pan-
creatic α-amylase activities by consuming food mixtures.
Current evidence supports the contention that the long-
term inhibitory action of α-glucosidase inhibitors contri-
butes to decreasing the level of HbA1c in diabetic
patients, resulting in a significant reduction in the inci-
dence of chronic vascular complication such as macro-
and micro-vascular diseases [32]. Consumption of
combinations of plant-based food may modify via addi-
tive and synergistic interactions, which may help to im-
prove postprandial hyperglycemia. This would offer a
greater benefit for the treatment and prevention of dia-
betic and its complications. The amount of plant-based
foods intake together is also required for further investi-
gation in diabetic patients.
Conclusion
In conclusion, the current study presents data from 5
plant-based foods evaluating the pancreatic α-amylase
and intestinal α-glucosidase inhibitory activities and
their additive and synergistic interactions. These results
could be useful for developing functional foods that en-
hance intestinal α-glucosidase and pancreatic α-amylase
inhibitory activities. For these reasons, further studies
should focus on the outcome of investigating effects in
in vivo activities.
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